157 related articles for article (PubMed ID: 36717764)
1. Serum cross-linked N-telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta-analysis.
Wang H; Hong M; Ding L; Song B
Thorac Cancer; 2023 Mar; 14(9):787-793. PubMed ID: 36717764
[TBL] [Abstract][Full Text] [Related]
2. Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.
Liu B; Zhao Y; Yuan J; Zeng L; Sun R; Meng X; Yang S
PLoS One; 2017; 12(11):e0187860. PubMed ID: 29182642
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.
Tamiya M; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Yasue T; Matsuura Y; Hirashima T; Kawase I
Med Oncol; 2012 Mar; 29(1):215-8. PubMed ID: 21258879
[TBL] [Abstract][Full Text] [Related]
4. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
5. Serum cross-linked N-telopeptide of type I collagen for the diagnosis of bone metastases from solid tumours in the Chinese population: Meta-analysis.
Zhang Y; Yi M; Cao J; Hou C; Zhou Y; Zhong Y
J Int Med Res; 2016 Apr; 44(2):192-200. PubMed ID: 26857861
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
[TBL] [Abstract][Full Text] [Related]
7.
Li L; Shen X; Liang Y; Li B; Si Y; Ma R
Heliyon; 2023 May; 9(5):e15980. PubMed ID: 37215848
[TBL] [Abstract][Full Text] [Related]
8. Can quantitative parameters of spectral computed tomography predict lymphatic metastasis in lung cancer? a systematic review and meta-analysis.
Wang T; Fan Z; Zou L; Hou Y
Radiother Oncol; 2023 Jun; 183():109643. PubMed ID: 36990392
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast-enhanced ultrasound: An updated meta-analysis.
Deng H; Lei J; Jin L; Shi H
Thorac Cancer; 2021 Nov; 12(21):2849-2856. PubMed ID: 34605207
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic validity of bone metabolic markers for bone metastasis.
Miura H; Yamamoto I; Takada M; Kigami Y; Ohta T; Yuu I; Hamanaka Y; Matsushita R; Morita R
Endocr J; 1997 Oct; 44(5):751-7. PubMed ID: 9466334
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) for diagnosis of bone metastasis in patients with primary lung cancer].
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):857-60. PubMed ID: 14727545
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
Cheng D; Sun Y; He H
Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma.
Izumi M; Nakanishi Y; Takayama K; Kimotsuki K; Inoue K; Wataya H; Minami T; Hara N
Cancer; 2001 Apr; 91(8):1487-93. PubMed ID: 11301396
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of bone resorption markers for the diagnosis of bone metastasis in lung cancer].
Nakamura H; Oishi S; Yagyu H; Morisako T; Kishi K; Tsuchida F; Adachi H; Sarashina G; Sudoh A; Hashimoto T; Matsuoka T
Nihon Kokyuki Gakkai Zasshi; 2002 May; 40(5):355-9. PubMed ID: 12166253
[TBL] [Abstract][Full Text] [Related]
17. Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.
Zhang L; Wang Y; Lei J; Tian J; Zhai Y
Acta Radiol; 2013 Sep; 54(7):770-7. PubMed ID: 23528566
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis.
Yang X; Cai Y; Xue B; Zhang B
J Int Med Res; 2021 Sep; 49(9):3000605211047714. PubMed ID: 34590880
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer.
Huang J; Gu T; Ying J
Int J Clin Oncol; 2017 Dec; 22(6):1015-1025. PubMed ID: 28677013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]